Gregory Verdeil
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Tumor-driven stabilization of CD8+ T cell exhaustion and implications for cancer immunotherapy.
Journal: Frontiers in immunology
Published: April 22, 2026
The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells.
Journal: The Journal of experimental medicine
Published: October 12, 2025
PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironment.
Journal: Journal for immunotherapy of cancer
Published: December 27, 2024
Dysregulation of cholesterol homeostasis in cancer pathogenesis.
Journal: Cellular and molecular life sciences : CMLS
Published: November 07, 2024
Tumor microenvironment squeezes out the juice from T cells.
Journal: Cell research
Published: June 10, 2024
Development of Traceable Mouse Models of Advanced and Metastatic Bladder Cancer.
Journal: Cancers
Published: May 17, 2024
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.
Journal: Nature communications
Published: February 19, 2024
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer.
Journal: Cancers
Published: October 26, 2023
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.
Journal: Nature
Published: May 22, 2023
c-MAF coordinates enterocyte zonation and nutrient uptake transcriptional programs.
Journal: The Journal of experimental medicine
Published: December 03, 2021
Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8+ T cell exhaustion.
Journal: Nature immunology
Published: September 09, 2021
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy.
Journal: Cancers
Published: August 19, 2021
Last Updated: 09/26/2026